Obesity is a global epidemic associated with over 200 health complications and a significant
risk of developing cardiovascular disease (CVD), partly by increasing classical risk factors …

Introduction Obesity is associated with an increased risk of cardiovascular morbidity and
mortality. Four medications are approved by the US Food and Drug Administration (FDA) for …

The global obesity epidemic and its impact on cardiovascular outcomes is a topic of ongoing
debate and investigation in the cardiology community. It is well known that obesity is …

Background Epidemiological data on obesity are needed, particularly in patients with type 2
diabetes mellitus (T2DM) and high cardiovascular (CV) risk. We used the baseline data of …

Aim To compare the benefits and harms of drugs approved for weight management in adults
with obesity or overweight. Materials and Methods We performed a systematic review of …

Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …

The prevalence of obesity and related comorbidities is increasing worldwide. Furthermore,
clinically meaningful body weight losses has proven difficult to achieve and especially to …

Introduction Obesity is highly prevalent in the US and is associated with an increased risk of
major adverse cardiovascular events (MACE). Modalities for the management of obesity …

Cardiovascular disease (CVD) is a leading global cause of death, with preventable risk
factors like obesity contributing most to it. Obesity's association with CVD originate from …

Background Obesity is a chronic disease with a myriad of complications including
cardiovascular disease. There is a growing interest to examine if obesity treatment is …